Number needed to treat with intravenous tenecteplase to reduce the need for mechanical thrombectomy in large vessel occlusion acute ischemic stroke patients: A retrospective look at real-world experience data
-
Published:2024-08
Issue:
Volume:126
Page:143-147
-
ISSN:0967-5868
-
Container-title:Journal of Clinical Neuroscience
-
language:en
-
Short-container-title:Journal of Clinical Neuroscience
Author:
Platko StevenORCID,
Bensabeur Fatima,
Peters David,
Darwich Noor,
Rotsching Nicholas,
Wagner Jacob,
Ugur Umran,
Reynolds Shelly,
Terry John B.,
Cheng-Ching Esteban
Reference24 articles.
1. Tanswell P, Modi N, Combs D, Danays T. Pharmacokinetics and Pharmacodynamics of Tenecteplase in Fibrinolytic Therapy of Acute Myocardial Infarction.; 2002.
2. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial;Logallo;Lancet Neurol,2017
3. Evidence that tenecteplase is noninferior to alteplase for acute ischemic stroke: meta-analysis of 5 randomized trials;Burgos;Stroke,2019
4. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials;Coutts;Int J Stroke,2018
5. Tenecteplase versus alteplase before endovascular thrombectomy (EXTEND-IA TNK): A multicenter, randomized, controlled study;Campbell;Int J Stroke,2018